L ow-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Costco customers can now buy Ozempic and Wegovy at the discount chain's drugstores. Novo Nordisk, the Danish pharmaceutical firm that makes the weight-loss drugs, announced Friday that Ozempic and ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Some people may notice weight gain while using Ozempic or after stopping the drug. Reasons for weight gain while using Ozempic may include changes in appetite and reduced physical activity due to side ...

The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.

Some good news on the weight-loss front: Customers can now go to Costco to get Ozempic and Wegovy, brand-name injectable prescription drugs manufactured by drugmaker Novo Nordisk, which contain the ...

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...

There is multidistrict litigation, or an MDL, in progress against pharmaceutical companies Novo Nordisk and Eli Lilly and Co. from parties allegedly suffering side effects caused by the active ...

Recently, an Iowa-based pharma company is dragged in an Ozempic lawsuit, reason? For selling counterfeit Ozempic. Ozempic is a popular drug used for diabetes and weight-loss. Its official website ...

In the past couple years, demand has gone wild for drugs like Ozempic – and its cousins, Zepbound, Wegovy, and Mounjaro. For people who had never been able to lose weight before, suddenly the numbers ...

Forbes contributors publish independent expert analyses and insights. Pam Danziger reports on retail, focused on the luxury consumer market. GLP-1 drugs like Ozempic are rapidly shifting American body ...